PD Dr. Thomas Ruhstaller, Stv. Chefarzt Brustzentrum St.Gallen comments the study:
Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)
(Paper):
ASCO2017Thomas Ruhstaller from Oncoletter on Vimeo.